Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2021-10-13, Stock:PFE, The news for the past five days is as follows:
2021-10-06: NEWS1: Former FDA Commissioner Scott Gottlieb on the Covid Pill, Vaccines for Kids.NEWS2: U.S. administers over 398 mln doses of COVID-19 vaccines - CDC.NEWS3: COVID SCIENCE-Booster shot improves immune response of chemotherapy patients; post-COVID depression helped by widely used drugs.NEWS4: ‘We’re Going to Have to Do Business Differently’: Scott Gottlieb on the Path Forward for Covid.NEWS5: UPDATE 2-Pfizer study to vaccinate whole Brazilian town against COVID-19.NEWS6: Mixing & matching covid boosters ‘might be a great opportunity’: Doctor.NEWS7: Allowing people to mix COVID-19 vaccines could cut into Pfizer and Moderna’s revenue next year.NEWS8: Italy says mRNA COVID jab effectiveness stable after 7 months, but not for all.NEWS9: Moderna (MRNA) Gets EMA Authorization for SpikeVax Third Dose.NEWS10: Voyager Therapeutics Stock Had Been Beaten Down. Here’s Why It’s Soaring..NEWS11: Why Novavax Stock Plunged in September.NEWS12: Voyager Therapeutics Stock, a Beaten-Down Biotech, Soars on Pfizer License Deal.NEWS13: Voyager Therapeutics Stock Soars on Potential $630M Deal With Pfizer.NEWS14: A Lyme Disease Vaccine From Pfizer and Valneva Will Have to Avoid the Pitfalls of the Past.NEWS15: UPDATE 4-Sweden, Denmark pause Moderna COVID-19 vaccine for younger age groups.NEWS16: Voyager Therapeutics stock rockets after license option deal with Pfizer that could be valued at $630 million.NEWS17: Shares of Vaccine Makers Continue to Reel Under Merck’s Covid Drug Potential.NEWS18: Voyager Therapeutics Announces License Option Agreement with Pfizer for Next-Generation TRACERᵀᴹ AAV Capsids to Enable Neurologic and Cardiovascular Gene Therapy Programs.NEWS19: Merck May Beat Pfizer to the COVID Pill Market. Does It Matter?.NEWS20: Could Pfizer's COVID Pill Be Better Than Merck's?.NEWS21: Lyme Disease Vaccine From Pfizer and Valneva Could Win Where Rival Lost.
2021-10-07: NEWS1: Booster discussion 'a bit convoluted': Doctor.NEWS2: Top Analyst Reports for Pfizer, American Tower & Intuitive Surgical.NEWS3: 'Administrative hurdles' could delay pediatric vaccine distribution: Doctor.NEWS4: Vaccine Stocks Pop As Pfizer, BioNTech Seek OK To Vaccinate Young Children.NEWS5: U.S. administers nearly 400 mln doses of COVID-19 vaccines - CDC.NEWS6: Pfizer Asks FDA to Authorize Covid-19 Vaccine in Young Children.NEWS7: Cousins Properties' (CUZ) Heights Union Buyout Fails to Drive Stock.NEWS8: 'Vaccine mandates are proving to work’: Doctor on Covid-19.NEWS9: Pfizer, BioNTech Seek Approval For COVID-19 Vaccine In Kids Aged 5-11: Reuters.NEWS10: After Sweden, Denmark Now Finland Stops Use of Moderna COVID-19 Jab In Young People: Report.NEWS11: News that children could soon be eligible for Pfizer-BioNTech vaccine cheers parents, as Biden pushes vaccine requirements in Chicago.NEWS12: Hopes that children will soon be eligible for Pfizer and BioNTech vaccine cheer parents, and Biden pushes vaccine requirements in Chicago.NEWS13: Voyager (VYGR) Surges on Gene Therapy Deal With Pfizer.NEWS14: Pfizer and BioNTech Asked FDA to Authorize Vaccine for Children.NEWS15: Down 9.7% in 4 Weeks, Here's Why You Should You Buy the Dip in Pfizer (PFE).NEWS16: Top Ranked Income Stocks to Buy for October 7th.NEWS17: Pfizer, BioNTech file for FDA authorization for their COVID-19 vaccine in children.NEWS18: UPDATE 4-Pfizer, BioNTech seek U.S. COVID-19 vaccine clearance for children 5-11.NEWS19: Pfizer, BioNTech ask U.S. regulators to OK COVID-19 vaccine for kids.NEWS20: Long-Covid Concerns Help Fuel Biden Administration’s Broad Vaccine Booster Push.NEWS21: Pfizer Seeks FDA Emergency-Use Approval for Covid Vaccine for Kids 5 to 11.NEWS22: What Do Mix-and-Match Doses Mean for Vaccine Stocks?.NEWS23: 3 Robinhood Dividend Stocks to Buy in October.NEWS24: Pfizer Gains as it Seeks FDA’s Emergency Nod for Child Covid Shot.NEWS25: Premarket Movers Thursday - Twitter, Levi Strauss, Pfizer, Costco, Disney.NEWS26: UPDATE 2-Finland joins Sweden and Denmark in limiting Moderna COVID-19 vaccine.NEWS27: UPDATE 4-Moderna plans African vaccine plant as drugmakers urged to help poorest.
2021-10-08: NEWS1: Southwest Airlines, Facebook, Pfizer: Stocks That Defined the Week.NEWS2: Italy widens COVID-19 vaccine booster campaign to frail and over 60s.NEWS3: U.S. administers more than 400 mln doses of COVID-19 vaccines - CDC.NEWS4: Studies claim Pfizer vaccine is less effective after a few months.NEWS5: UPDATE 1-U.S. CDC advisers to review Moderna, J&J COVID-19 booster shots this month.NEWS6: Covid-19 Vaccine Boosters Are Outpacing First Doses. What Vaccine Stocks Are Doing..NEWS7: Covid-19 Vaccine Boosters Now Outpace First Doses, CDC Data Show.NEWS8: The Zacks Analyst Blog Highlights: Pfizer, American Tower Corp, Intuitive Surgical, Fidelity National Information Services and FedEx.NEWS9: Finland joins other Nordic nations in curbing Moderna shots.NEWS10: Is Principal U.S. MegaCap ETF (USMC) a Strong ETF Right Now?.NEWS11: UPDATE 1-Denmark says Moderna vaccine remains available to under-18s.NEWS12: 10 Best Big Pharma Stocks to Buy Now.NEWS13: Tesla, Quidel, Chubb Rise Premarket; Allogene Tumbles.NEWS14: COVID Update: Vaccine Booster Shots, Alternate Treatments Wrap Up.NEWS15: REFILE-Malaysia approves Pfizer-BioNTech vaccine for booster dose.NEWS16: UPDATE 1-Japan secures 120 mln more Pfizer COVID-19 vaccine doses for next year.NEWS17: Brazil in talks to buy up to 150 mln Pfizer COVID-19 vaccines for 2022.
2021-10-11: NEWS1: International SOS SVP details where doctors have been needed most.NEWS2: Pfizer (PFE) Dips More Than Broader Markets: What You Should Know.NEWS3: Pfizer-BioNTech Covid-19 Vaccine Is World’s Preferred Shot.NEWS4: Coronavirus: Doctor quotes Yogi Berra to urge everyone to 'let the data sort itself out'.NEWS5: Pfizer (PFE) is a Top-Ranked Growth Stock: Should You Buy?.NEWS6: Merck seeks emergency authorization for COVID pill.NEWS7: 4 Key Things Investors Should Know About Pfizer's Experimental COVID-19 Pill.
2021-10-12: NEWS1: Breaking down the legality of workplace vaccine mandates.NEWS2: eMed CEO discusses what's next for COVID-19 testing.NEWS3: U.S. administers 403.6 mln doses of COVID-19 vaccines - CDC.NEWS4: FDA Staff Don’t Take Position on Moderna Covid-19 Booster.NEWS5: Pushing back on businesses’ ability to have a vaccine mandate is a bad idea: Doctor.NEWS6: An FDA committee will discuss Moderna boosters. Here's what to expect.NEWS7: FDA Scientists Decline to Take Stance on Moderna Covid Booster Shot.NEWS8: FDA working to authorize booster shots of Moderna and J&J vaccines.NEWS9: Sanofi’s Covid Vaccine Inches Closer to the Market, Analyst Says.NEWS10: Sanofi’s Covid-19 Vaccine Gets a Boost From Early Testing Data, Analyst Says.NEWS11: Pre-Markets Back to Green Ahead of Economic & Earnings Data.NEWS12: UPDATE 2-GSK says on course to demerge consumer arm after report of buyout interest.NEWS13: GSK on track with consumer split as buyout report boosts shares.NEWS14: How Could Pfizer Be Affected by Moderna's Vaccine Safety Issues?.NEWS15: Where the S&P and Nasdaq Stand, The New Green Team, Trading Southwest and Pfizer.NEWS16: FDA Advisory Panel Will Debate J&J and Moderna Boosters This Week.

Answer: Decrease